0

Close
 
Upcoming Allied Market Research
2023
Hirsutism Market

Hirsutism Market: Global Opportunity Analysis and Industry Forecast 2023-2030 Market

LS : Healthcare
Report Code: A10477
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Hirsutism Market

Request Now !

Hirsutism is stiff or dark body hair, appearing on the body where women don't commonly have hair — primarily the face, chest, lower abdomen, inner thighs and back.  It is a condition in women that results in excessive growth of dark or coarse hair in a male-like pattern. People have widely varying opinions on what's considered excessive. When high androgen levels cause hirsutism, other signs might develop over time, a process called virilization. Self-care methods and effective treatment options are available for women who wish to treat hirsutism.

Impact of Covid-19 on the market:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine, have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Facial hair is considered as undesirable for women worldwide, which has increased the cosmetic as well as psychological problems regarding unwanted hair. This is estimated to drive the hirsutism market growth. Global beauty standards in various cultures do not approve of body hair. Hence, it put immense pressure on the patients to comply with normative beauty and aesthetic standards. These aspects are driving the demand of laser hair removal because of its higher efficacy. Rise in treatment awareness, technological advancements and rise in personal care expenditure along with rise in R&D and new product launches are estimated to drive the hirsutism market growth.

However, alternative methods of hirsutism management, such as topical creams and plucking, are relatively not as effective as laser hair removal and might hinder the hirsutism market growth.

Rise in demand of Hair Removal Equipment:

Hair removal equipment, such as laser and intense pulsed light (IPL) equipment are estimated to drive the market growth. These equipment’s target the hair follicles and give long term results. These treatments require multiple treatment sessions, because the hair needs to be removed during the growth phase.

Development of Technology:

Initially, Intense pulse light (IPL) with square pulse technology was used. With the development of technology the demand for laser hair removal is increasing, owing to its better efficacy, as compared to other methods of hirsutism management. Hence, technology advancements act as one of the growth drivers. However, there is no literature on use of IPL on the Indian skin.

Key Benefits of the Report:

  • This study presents the analytical depiction of the global hirsutism.
  • hirsutism market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global hirsutism Market share.
  • The current market is quantitatively analyzed to highlight the global hirsutism market growth scenario.
  • The report provides a detailed global hirsutism Market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the hirsutism market research report:

  • Which are the leading market players active in the hirsutism market since few years?
  • What are the driving factors, challenges, and opportunities in the hirsutism market?
  • What are the projections for the future that would help in taking further strategic steps?

 Hirsutism Market: Global Opportunity Analysis and Industry Forecast 2020–2027 Report Highlights

Aspects Details
By Therapy Type
  • Procedures
  • Medication
By End User
  • Hospitals
  • Clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Sciton Inc., Lumenis Inc.,, Allergan PLC,, Nisim Inc.,, Cynosure Inc.,, Bausch Health Companies Inc. (Solta Medical Inc.),, Alpaya Dermaceuticals,, Wet and Dry Personal Care,, Ajanta Pharma,, Alma Lasers Ltd,
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: HIRSUTISM MARKET, BY THERAPY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Therapy Type

    • 4.2. Procedures

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Medication

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: HIRSUTISM MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: HIRSUTISM MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Therapy Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Hirsutism Market

        • 6.2.5.1. Market Size and Forecast, By Therapy Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Hirsutism Market

        • 6.2.6.1. Market Size and Forecast, By Therapy Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Hirsutism Market

        • 6.2.7.1. Market Size and Forecast, By Therapy Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Therapy Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Hirsutism Market

        • 6.3.5.1. Market Size and Forecast, By Therapy Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Hirsutism Market

        • 6.3.6.1. Market Size and Forecast, By Therapy Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Hirsutism Market

        • 6.3.7.1. Market Size and Forecast, By Therapy Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Hirsutism Market

        • 6.3.8.1. Market Size and Forecast, By Therapy Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Hirsutism Market

        • 6.3.9.1. Market Size and Forecast, By Therapy Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Hirsutism Market

        • 6.3.10.1. Market Size and Forecast, By Therapy Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Hirsutism Market

        • 6.3.11.1. Market Size and Forecast, By Therapy Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Therapy Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Hirsutism Market

        • 6.4.5.1. Market Size and Forecast, By Therapy Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Hirsutism Market

        • 6.4.6.1. Market Size and Forecast, By Therapy Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Hirsutism Market

        • 6.4.7.1. Market Size and Forecast, By Therapy Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Hirsutism Market

        • 6.4.8.1. Market Size and Forecast, By Therapy Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Hirsutism Market

        • 6.4.9.1. Market Size and Forecast, By Therapy Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Hirsutism Market

        • 6.4.10.1. Market Size and Forecast, By Therapy Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Hirsutism Market

        • 6.4.11.1. Market Size and Forecast, By Therapy Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Hirsutism Market

        • 6.4.12.1. Market Size and Forecast, By Therapy Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Hirsutism Market

        • 6.4.13.1. Market Size and Forecast, By Therapy Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Therapy Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Hirsutism Market

        • 6.5.5.1. Market Size and Forecast, By Therapy Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Hirsutism Market

        • 6.5.6.1. Market Size and Forecast, By Therapy Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Hirsutism Market

        • 6.5.7.1. Market Size and Forecast, By Therapy Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Hirsutism Market

        • 6.5.8.1. Market Size and Forecast, By Therapy Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Hirsutism Market

        • 6.5.9.1. Market Size and Forecast, By Therapy Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Hirsutism Market

        • 6.5.10.1. Market Size and Forecast, By Therapy Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Allergan PLC,

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Ajanta Pharma,

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Alpaya Dermaceuticals,

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Nisim Inc.,

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Wet And Dry Personal Care,

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Bausch Health Companies Inc. (Solta Medical Inc.),

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Cynosure Inc.,

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Lumenis Inc.,

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Alma Lasers Ltd,

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Sciton Inc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL HIRSUTISM MARKET, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL HIRSUTISM MARKET FOR PROCEDURES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL HIRSUTISM MARKET FOR MEDICATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL HIRSUTISM MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL HIRSUTISM MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL HIRSUTISM MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL HIRSUTISM MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL HIRSUTISM MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA HIRSUTISM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. U.S. HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. U.S. HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. CANADA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. CANADA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE HIRSUTISM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. FRANCE HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. FRANCE HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. GERMANY HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. ITALY HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. ITALY HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. UK HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. UK HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. RUSSIA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. RUSSIA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC HIRSUTISM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. CHINA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. CHINA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. INDIA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. INDIA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. THAILAND HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. THAILAND HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. MALAYSIA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. MALAYSIA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. INDONESIA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. INDONESIA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. LAMEA HIRSUTISM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. LAMEA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. BRAZIL HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. BRAZIL HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. SOUTH AFRICA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH AFRICA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SAUDI ARABIA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SAUDI ARABIA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. UAE HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. UAE HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ARGENTINA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. ARGENTINA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. REST OF LAMEA HIRSUTISM, BY THERAPY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF LAMEA HIRSUTISM, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ALLERGAN PLC,: KEY EXECUTIVES
  • TABLE 72. ALLERGAN PLC,: COMPANY SNAPSHOT
  • TABLE 73. ALLERGAN PLC,: OPERATING SEGMENTS
  • TABLE 74. ALLERGAN PLC,: PRODUCT PORTFOLIO
  • TABLE 75. ALLERGAN PLC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. AJANTA PHARMA,: KEY EXECUTIVES
  • TABLE 77. AJANTA PHARMA,: COMPANY SNAPSHOT
  • TABLE 78. AJANTA PHARMA,: OPERATING SEGMENTS
  • TABLE 79. AJANTA PHARMA,: PRODUCT PORTFOLIO
  • TABLE 80. AJANTA PHARMA,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. ALPAYA DERMACEUTICALS,: KEY EXECUTIVES
  • TABLE 82. ALPAYA DERMACEUTICALS,: COMPANY SNAPSHOT
  • TABLE 83. ALPAYA DERMACEUTICALS,: OPERATING SEGMENTS
  • TABLE 84. ALPAYA DERMACEUTICALS,: PRODUCT PORTFOLIO
  • TABLE 85. ALPAYA DERMACEUTICALS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. NISIM INC.,: KEY EXECUTIVES
  • TABLE 87. NISIM INC.,: COMPANY SNAPSHOT
  • TABLE 88. NISIM INC.,: OPERATING SEGMENTS
  • TABLE 89. NISIM INC.,: PRODUCT PORTFOLIO
  • TABLE 90. NISIM INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. WET AND DRY PERSONAL CARE,: KEY EXECUTIVES
  • TABLE 92. WET AND DRY PERSONAL CARE,: COMPANY SNAPSHOT
  • TABLE 93. WET AND DRY PERSONAL CARE,: OPERATING SEGMENTS
  • TABLE 94. WET AND DRY PERSONAL CARE,: PRODUCT PORTFOLIO
  • TABLE 95. WET AND DRY PERSONAL CARE,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: KEY EXECUTIVES
  • TABLE 97. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: COMPANY SNAPSHOT
  • TABLE 98. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: OPERATING SEGMENTS
  • TABLE 99. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: PRODUCT PORTFOLIO
  • TABLE 100. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. CYNOSURE INC.,: KEY EXECUTIVES
  • TABLE 102. CYNOSURE INC.,: COMPANY SNAPSHOT
  • TABLE 103. CYNOSURE INC.,: OPERATING SEGMENTS
  • TABLE 104. CYNOSURE INC.,: PRODUCT PORTFOLIO
  • TABLE 105. CYNOSURE INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. LUMENIS INC.,: KEY EXECUTIVES
  • TABLE 107. LUMENIS INC.,: COMPANY SNAPSHOT
  • TABLE 108. LUMENIS INC.,: OPERATING SEGMENTS
  • TABLE 109. LUMENIS INC.,: PRODUCT PORTFOLIO
  • TABLE 110. LUMENIS INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. ALMA LASERS LTD,: KEY EXECUTIVES
  • TABLE 112. ALMA LASERS LTD,: COMPANY SNAPSHOT
  • TABLE 113. ALMA LASERS LTD,: OPERATING SEGMENTS
  • TABLE 114. ALMA LASERS LTD,: PRODUCT PORTFOLIO
  • TABLE 115. ALMA LASERS LTD,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. SCITON INC.: KEY EXECUTIVES
  • TABLE 117. SCITON INC.: COMPANY SNAPSHOT
  • TABLE 118. SCITON INC.: OPERATING SEGMENTS
  • TABLE 119. SCITON INC.: PRODUCT PORTFOLIO
  • TABLE 120. SCITON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL HIRSUTISM MARKET SEGMENTATION
  • FIGURE 2. GLOBAL HIRSUTISM MARKET
  • FIGURE 3. SEGMENTATION HIRSUTISM MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN HIRSUTISM MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHIRSUTISM MARKET
  • FIGURE 11. HIRSUTISM MARKET SEGMENTATION, BY BY THERAPY TYPE
  • FIGURE 12. HIRSUTISM MARKET FOR PROCEDURES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. HIRSUTISM MARKET FOR MEDICATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. HIRSUTISM MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. HIRSUTISM MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. HIRSUTISM MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. HIRSUTISM MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: HIRSUTISM MARKET
  • FIGURE 24. Top player positioning, 2022
  • FIGURE 25. ALLERGAN PLC,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 26. ALLERGAN PLC,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 27. ALLERGAN PLC,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 28. AJANTA PHARMA,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. AJANTA PHARMA,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. AJANTA PHARMA,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. ALPAYA DERMACEUTICALS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. ALPAYA DERMACEUTICALS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. ALPAYA DERMACEUTICALS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. NISIM INC.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. NISIM INC.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. NISIM INC.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. WET AND DRY PERSONAL CARE,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. WET AND DRY PERSONAL CARE,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. WET AND DRY PERSONAL CARE,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.),: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. CYNOSURE INC.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. CYNOSURE INC.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. CYNOSURE INC.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. LUMENIS INC.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. LUMENIS INC.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. LUMENIS INC.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. ALMA LASERS LTD,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. ALMA LASERS LTD,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. ALMA LASERS LTD,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. SCITON INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. SCITON INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. SCITON INC.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Hirsutism Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers